Vigil Neuroscience Inc’s filing revealed that its Director Budd Haeberlein Samantha L. acquired Company’s shares for reported $20520.0 on Dec 19 ’24. In the deal valued at $1.71 per share,12,000 shares were bought. As a result of this transaction, Budd Haeberlein Samantha L. now holds 12,000 shares worth roughly $94560.0.
Then, Magovcevic-Liebisch Ivana bought 5,000 shares, generating $8,400 in total proceeds. Upon buying the shares at $1.68, the President and CEO now owns 222,687 shares.
Before that, Magovcevic-Liebisch Ivana bought 5,000 shares. Vigil Neuroscience Inc shares valued at $8,350 were divested by the President and CEO at a price of $1.67 per share. As a result of the transaction, Magovcevic-Liebisch Ivana now holds 217,687 shares, worth roughly $1.72 million.
Stifel downgraded its Vigil Neuroscience Inc [VIGL] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in early December with a ‘”an Outperform”‘ rating. Morgan Stanley also remained covering VIGL and has decreased its forecast on December 19, 2023 with a “an Underweight” recommendation from previously “an Equal-weight” rating. JMP Securities started covering the stock on October 18, 2023. It rated VIGL as “a Mkt outperform”.
Price Performance Review of VIGL
On Friday, Vigil Neuroscience Inc [NASDAQ:VIGL] saw its stock unchanged to $7.88. Over the last five days, the stock has lost -0.13%. Vigil Neuroscience Inc shares have risen nearly 363.53% since the year began. Nevertheless, the stocks have risen 213.94% over the past one year. While a 52-week high of $7.95 was reached on 05/22/25, a 52-week low of $1.31 was recorded on 04/09/25. SMA at 50 days reached $3.30, while 200 days put it at $2.92.
Levels Of Support And Resistance For VIGL Stock
The 24-hour chart illustrates a support level at 7.87, which if violated will result in even more drops to 7.86. On the upside, there is a resistance level at 7.89. A further resistance level may holdings at 7.90. The Relative Strength Index (RSI) on the 14-day chart is 89.35, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.17, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 1.22%. Stochastics %K at 98.89% indicates the stock is a selling.
The most recent change occurred on March 31, 2023 when Mizuho began covering the stock and recommended ‘”a Buy”‘ rating along with a $15 price target.
